The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
Open accessAbstract
Serum levels of interleukin-10 (IL-10) are elevated in a proportion of patients with untreated chronic hepatitis C, and this may compromise the host immune response to the virus. The capacity for IL-10 production varies according to the genetic composition of the IL-10 locus. We examined the inheritance of 3 biallelic polymorphisms in the IL-10 gene promoter in patients with chronic hepatitis C and their association with response to treatment with interferon alfa (IFN-α). After adjusting for potential confounding variables, a highly significant relationship was found between inheritance of the IL-10 promoter −592*A and −819*T alleles or the ATA haplotype and response to IFN-α therapy (P = .016). Response to treatment was also associated with viral genotype 3a, a low viral load, and less fibrosis on liver biopsy. Following in vitro stimulation of peripheral blood mononuclear cells, the IL-10 promoter haplotypes, GCC, ACC, and ATA, were associated with high, intermediate, and low IL-10 production, respectively. These findings indicate that heterogeneity in the promoter region of the IL-10 gene has a role in determining the initial response of chronic hepatitis C to IFN-α therapy. Patients who are genetically predisposed to high IL-10 production have a poor response to IFN-α and may benefit from additional treatment strategies designed to enhance a T-helper type 1 (Th1) response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,865
AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTER
Turner, D. M., Williams, D. M., Sankaran, D., Lazarus, M., Sinnott, P. J., & Hutchinson, I. V. (1997) · European Journal of Immunogenetics · doi:10.1111/j.1365-2370.1997.tb00001.x · Cited by 1,717
Classification of chronic viral hepatitis: a need for reassessment
Scheuer, P. J. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90084-o · Cited by 1,576
The Treatment of Chronic Viral Hepatitis
Hoofnagle, J. H., & Di Bisceglie, A. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701303360507 · Cited by 946
Genetic influence on cytokine production and fatal meningococcal disease
Westendorp, R. G., Langermans, J. A., Huizinga, T. W., Elouali, A. H., Verweij, C. L., Boomsma, D. I., & Vandenbrouke, J. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)06413-6 · Cited by 800
Hepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Weiner, A. J., Geysen, H. M., Christopherson, C., Hall, J. E., Mason, T. J., Saracco, G., Bonino, F., Crawford, K., Marion, C. D., & Crawford, K. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3468 · Cited by 704
Properties and Functions of Interleukin-10
Mosman, T. R. (1994) · Advances in Immunology · doi:10.1016/s0065-2776(08)60449-6 · Cited by 500
Interleukin 10 secretion in relation to human IL-10 locus haplotypes
Eskdale, J., Gallagher, G., Verweij, C. L., Keijsers, V., Westendorp, R. G. J., & Huizinga, T. W. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9465 · Cited by 467
Napoli, J., Bishop, G. A., McGuinness, P. H., Painter, D. M., & McCaughan, G. W. (1996) · Hepatology · doi:10.1002/hep.510240402 · Cited by 412
Clerici, M., Wynn, T. A., Berzofsky, J. A., Blatt, S. P., Hendrix, C. W., Sher, A., Coffman, R. L., & Shearer, G. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117031 · Cited by 390
Factors predictive of a beneficial response to therapy of hepatitis C
Davis, G. L., & Lau, J. Y. (1997) · Hepatology · doi:10.1002/hep.510260721 · Cited by 325
Cacciarelli, T. V., Martinez, O. M., Gish, R. G., Villanueva, J. C., & Krams, S. M. (1996) · Hepatology · doi:10.1002/hep.510240102 · Cited by 284
Haplotype associated with low interleukin-10 production in patients with severe asthma
Lim, S., Crawley, E., Woo, P., & Barnes, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)85018-6 · Cited by 280
Perrey, C., Pravica, V., Sinnott, P. J., & Hutchinson, I. V. (1998) · Transplant Immunology · doi:10.1016/s0966-3274(98)80045-2 · Cited by 257
Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus.
Lazarus, M. N., Hajeer, A. H., Turner, D. M., Sinnott, P. J., Worthington, J., Ollier, W., & Hutchinson, I. V. (1997) · PubMed · Cited by 239
IL-10 Gene Promoter Polymorphisms in Rheumatoid Arthritis: SHORT REPORT
Hajeer, A. H. (1998) · Scandinavian Journal of Rheumatology · doi:10.1080/030097498441029 · Cited by 146
Tsai, S., Chen, Y.-M., Chen, M.-H., Huang, C., Sheen, I., Yeh, C., Huang, J.-H., Kuo, G. C., & Liaw, Y. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70268-9 · Cited by 140
Interleukin-10 and its receptor.
Ho, A. S., & Moore, K. W. (1994) · PubMed · Cited by 100
Knolle, P. A., Uhrig, A., Protzer, U., Trippler, M., Duchmann, R., Büschenfelde, K. M. Z., & Gerken, G. (1998) · Hepatology · doi:10.1002/hep.510270116 · Cited by 91
Payvandi, F., Amrute, S. B., & Fitzgerald-Bocarsly, P. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5861 · Cited by 86
Payvandi, F., Amrute, S. B., & Fitzgerald-Bocarsly, P. A. (1998) · PubMed · Cited by 85
Detection of hepatocellular carcinoma in cirrhotic livers with lipiodol-ct
Valls, C., Figueras, J., Bhattacjarya, S., et al. (1998) · Hepatology · doi:10.1002/hep.510280140 · Cited by 5
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
van den Biggelaar, A. H., van Ree, R., Rodrigues, L. C., Lell, B., Deelder, A. M., Kremsner, P. G., & Yazdanbakhsh, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03206-2 · Cited by 705
Genetics of susceptibitlity to human infectious disease
Cooke, G. S., & Hill, A. V. S. (2001) · Nature Reviews Genetics · doi:10.1038/35103577 · Cited by 444
Host genetic factors influence disease progression in chronic hepatitis C
Powell, E. E., Edwards-Smith, C. J., Hay, J. L., Clouston, A. D., Crawford, D. H., Shorthouse, C., Purdie, D. M., & Jonsson, J. R. (2000) · Hepatology · doi:10.1053/he.2000.6253 · Cited by 398
Self-citation
Metadata
- Authors
- Edwards-Smith, C. J., Jonsson, J. R., Purdie, D. M., Bansal, A., Shorthouse, C., & Powell, E. E.
- Venue
- Hepatology
- Published
- 1999-08
- Volume
- 30
- Issue
- 2
- Pages
- 526-530
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2016283253
- Cited by
- 404
- References
- 25
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.